title: Bortezomib: a therapeutic resource for the veterinary oncologist?
authors.affiliation: Reata Pharmaceuticals, 2801 Gateway Dr. Ste 150, Irving, TX 75063, USA. Electronic address: scott.reisman@reatapharma.com.
authors.forename: Scott A
authors.initials: SA
authors.lastname: Reisman
mesh_terms: D000818:Animals; D001897:Boronic Acids / Q000494:pharmacology*; D000069286:Bortezomib; D004283:Dog Diseases / Q000188:drug therapy*; D008545:Melanoma / Q000662:veterinary*; D016328:NF-kappa B / Q000378:metabolism*; D061988:Proteasome Inhibitors / Q000494:pharmacology*; D011719:Pyrazines / Q000494:pharmacology*; D015398:Signal Transduction / Q000187:drug effects*; D012878:Skin Neoplasms; D000096142:Cutaneous Malignant Melanoma
chemical_list: D001897:Boronic Acids; D016328:NF-kappa B; D061988:Proteasome Inhibitors; D011719:Pyrazines; D000069286:Bortezomib